Monte Rosa Therapeutics Inc (GLUE) support and resistance · rev $13.2M
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
This page maps Monte Rosa Therapeutics Inc (GLUE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
GLUE currently screens at market cap $1.56B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new GLUE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the GLUE quote page for the session range and the stock page for the full model.
Not investment advice.